CD4+ T lymphocytes mediate acute pulmonary ischemia–reperfusion injury

Slides:



Advertisements
Similar presentations
Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion  Babu V Naidu, FRCS, Steven M Woolley, MRCS, Alexander S Farivar,
Advertisements

One-lung ventilation: For how long?
Inhibition of Na-K-Cl cotransporter isoform 1 reduces lung injury induced by ischemia– reperfusion  Chou-Chin Lan, MD, PhD, Chung-Kan Peng, MD, PhD, Shih-En.
Prevention of lung ischemia–reperfusion injury by short hairpin RNA–mediated caspase- 3 gene silencing  Yong-Xing Zhang, MD, Hong Fan, PhD, Yu Shi, MD,
Simvastatin attenuates cardiac isograft ischemia-reperfusion injury by down-regulating CC chemokine receptor-2 expression  Rong Yin, MD, Jiaquan Zhu,
Ugonna N. Ihekweazu, BS, William D. Travis, MD, Raja M. Flores, MD 
Mary E. Huerter, MD, MA, Ashish K
Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats 
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
The influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: A randomized trial  Christian.
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice  Bob Lubamba, François Huaux, Jean Lebacq, Etienne Marbaix,
Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans  Katharina Krenn, MD, Matthias Gmeiner, MD, PhD, Patrick Paulus, MD, Nezir.
Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion  Babu V Naidu, FRCS, Steven M Woolley, MRCS, Alexander S Farivar,
Carbon monoxide reduces pulmonary ischemia–reperfusion injury in miniature swine  Hisashi Sahara, MD, Akira Shimizu, MD, PhD, Kentaro Setoyama, DVM, PhD,
Baiya Krishnadasan, MD, Babu V
Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant  Victor van Berkel, MD, PhD 
Volume 74, Issue 7, Pages (October 2008)
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injury  Ashish K. Sharma, MBBS, Victor E.
Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase.
J. Hunter Mehaffey, MD, Eric J. Charles, MD, Ashish K
Volume 86, Issue 2, Pages (August 2014)
Pulmonary vein stenosis: Challenges ahead
Ex vivo rehabilitation of non–heart-beating donor lungs in preclinical porcine model: Delayed perfusion results in superior lung function  Daniel P. Mulloy,
The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation  T.
Allograft carotid artery as a systemic-to-pulmonary conduit
Eric J. Charles, MD, Mary E. Huerter, MD, MA, Cynthia E
Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death  Cynthia E. Wagner,
Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury
Victor van Berkel, MD, PhD 
Effect of preoperative inhaled budesonide on pulmonary injury after cardiopulmonary bypass: A randomized pilot study  Wei Gao, MD, Na Li, MS, Zhe-hao.
Surfactant Improves Graft Function After Gastric Acid–Induced Lung Damage in Lung Transplantation  Ilhan Inci, MD, Sven Hillinger, MD, Stephan Arni, PhD,
William M. DeCampli, MD, PhD 
Nebulized nitrite protects rat lung grafts from ischemia reperfusion injury  Toshihiro Okamoto, MD, PhD, Xiaoying Tang, MS, Allison Janocha, BS, Caral.
Pretreatment with bone marrow–derived mesenchymal stromal cell–conditioned media confers pulmonary ischemic tolerance  Billanna Hwang, MPH, W. Conrad.
How should we treat air leaks?
Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage.
Activated protein C attenuates cardiopulmonary bypass–induced acute lung injury through the regulation of neutrophil activation  Sachiko Yamazaki, MD,
Carbon monoxide–saturated preservation solution protects lung grafts from ischemia– reperfusion injury  Junichi Kohmoto, MD, Atsunori Nakao, MD, Ryujiro.
Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis  Pedro R. Moreno, MD, Luis Astudillo, MD, Sammy.
Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A2A receptor activation  Turner C. Lisle, MD, Leo M. Gazoni, MD, Lucas.
The lord of the rings  Antonio Miceli, MD, PhD 
Jared P. Beller, MD, Irving L. Kron, MD 
Is tissue the issue?  Brian E. Louie, MD, MHA, MPH, FRCSC, FACS 
Denis W. Harkin, MD, Aires A. B
Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus  B. Krishnadasan, MD, B. Naidu, MBBS,
Yang Zhang, MD, Haiquan Chen, MD, PhD 
A first start for lung transplantation?
Ashok Muniappan, MD  The Journal of Thoracic and Cardiovascular Surgery 
Validating the use of short interfering RNA as a novel technique for cell-specific target gene knockdown in lung ischemia–reperfusion injury  Heather.
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Importance of endothelial nitric oxide synthase for the hypothermic protection of lungs against ischemia-reperfusion injury  Li Zhang, MD, Sanjeev Kumar,
Which is better to preserve pulmonary function: Short-term or prolonged leukocyte depletion during cardiopulmonary bypass?  Kaiyu Tao, MD, Qi An, MD,
Daniel P. Mulloy, MD, Ashish K. Sharma, MBBS, PhD, Lucas G
Hyperoxic ventilation exacerbates lung reperfusion injury
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
How much is enough to warrant prophylactic tricuspid repair?
One-lung ventilation: For how long?
Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation  Scott D Ross, MD, Curtis G Tribble, MD, John R Gaughen,
Inhibitory kappa B kinase-β is a target for specific nuclear factor kappa B-mediated delayed cardioprotection  Nancy C. Moss, MD, Ru-Hang Tang, PhD, Monte.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tissue valve, nitinol stent, or storage solution
The future of cardiac surgery training: A survival guide
Commentary: Avoiding acute kidney injury after cardiac operations: Searching for the holy grail is not easy  Victor A. Ferraris, MD, PhD  The Journal.
Energized lung resections
Preoperative PFTs: The answer is blowing in the wind
Lucas G. Fernandez, MD, DSc, Timothy D
Who should decide margin length in pulmonary excision of lung cancer?
Edward Y. Chan, MD, Michael J. Reardon, MD 
Deciding how much to pay for effective care
Presentation transcript:

CD4+ T lymphocytes mediate acute pulmonary ischemia–reperfusion injury Zequan Yang, MD, PhD, Ashish K. Sharma, MBBS, Joel Linden, PhD, Irving L. Kron, MD, Victor E. Laubach, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 137, Issue 3, Pages 695-702 (March 2009) DOI: 10.1016/j.jtcvs.2008.10.044 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Complete blood cell counts in antibody-treated mice. A, Before hilar ligation, there was an 80% reduction in neutrophils in neutrophil-depleted mice compared with IgG control mice, a 19% reduction in lymphocytes in CD8-depleted mice, and a 26% reduction of lymphocytes in CD4-depleted mice. ∗P < .05 versus IgG control mice. B, Reperfusion caused a significant decrease in total circulating leukocytes and lymphocytes in all antibody-treated mice. However, circulating neutrophils also increased after reperfusion, but this was significant only in IgG control mice. #P < .05 versus the corresponding group in panel A. WBC, Total white blood cells. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 695-702DOI: (10.1016/j.jtcvs.2008.10.044) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Myeloperoxidase (MPO) levels and leukocyte subtype infiltration into peripheral lung tissue after reperfusion. A, Myeloperoxidase levels in bronchoalveolar lavage fluid after reperfusion. ∗P < .05 versus sham mice. B, Examples of immunohistochemical staining for neutrophils, CD3+ T cells, and macrophages in the study groups. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 695-702DOI: (10.1016/j.jtcvs.2008.10.044) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Effect of leukocyte subtype depletion on pulmonary function after reperfusion. Airway resistance, lung compliance, and pulmonary artery pressure were significantly improved in neutrophil-depleted and CD4+ T cell–depleted mice. No protection was observed in CD8+ T cell–depleted mice. ∗P < .05 versus sham mice. #P < .05 versus IgG control and CD8-depleted mice. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 695-702DOI: (10.1016/j.jtcvs.2008.10.044) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Microvascular permeability and pulmonary edema. A, Evans blue content in lung tissue as an indicator of microvascular leak. In antibody-treated mice Evans blue content was more significantly increased in IgG control and CD8-depleted mice than in neutrophil-depleted or CD4-depleted mice. B, Lung wet/dry weight ratio, as an indicator of edema, was significantly increased in IgG control and CD8-depleted mice but not in neutrophil-depleted or CD4-depleted mice (Figure 5, B). ∗P < .05 versus sham mice. #P < .05 versus IgG control and CD8-depleted mice. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 695-702DOI: (10.1016/j.jtcvs.2008.10.044) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Expression of cytokines/chemokines in bronchoalveolar lavage fluid. CCL3 (macrophage inflammatory protein 1), tumor necrosis factor α (TNF-α), interleukin 17 (IL-17), and CXCL1 (KC) levels were all significantly increased in IgG control, neutrophil-depleted, and CD8-depleted mice compared with those seen in sham mice. In CD4-depleted mice there was no significant difference in CCL3, IL-17, and CXCL1 levels compared with those seen in sham mice. CXCL1 levels in CD4-depleted mice were significantly lower than in all other antibody-treated mice. ∗P < .05 versus IgG control mice. #P < .05 versus CD8-depleted mice. †P < .05 versus neutrophil-depleted mice. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 695-702DOI: (10.1016/j.jtcvs.2008.10.044) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions